# 68Ga-NTA-476 Imaging in Prostate Cancer

> **NCT06520449** · EARLY_PHASE1 · COMPLETED · sponsor: **Melbourne Theranostic Innovation Centre** · enrollment: 10 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** 68Ga-NTA-476

## Key facts

- **NCT ID:** NCT06520449
- **Lead sponsor:** Melbourne Theranostic Innovation Centre
- **Sponsor class:** NETWORK
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-13
- **Primary completion:** 2024-12-12
- **Final completion:** 2025-01-17
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06520449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06520449, "68Ga-NTA-476 Imaging in Prostate Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06520449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*